Sign in

You're signed outSign in or to get full access.

Lyndon Oliver

Regional President, Asia at METLIFEMETLIFE
Executive

About Lyndon Oliver

Lyndon Oliver is Regional President, Asia at MetLife and a member of the executive leadership team, with over 35 years in the insurance and financial services industry . He previously served as Executive Vice President and Treasurer of MetLife, signing multiple SEC documents and financing agreements in 2020–2021, evidencing his leadership in capital markets and corporate treasury functions . During his Asia tenure, Oliver has discussed growth drivers and headwinds, including FX-rate advantages for foreign currency products, VII variability, and surrender dynamics in Japan, providing operational insight into segment performance . Company-level performance context: 2024 Core Adjusted ROE was 15.2% (above 13–15% target), Core Adjusted Earnings were $5.8B, and Core Adjusted EPS was $8.11; MetLife returned ~$4.7B to shareholders, and the Company’s five-year total shareholder return (value of $100) exceeded the peer index in 2024 per Pay vs Performance disclosures .

Past Roles

OrganizationRoleYearsStrategic Impact
MetLife, Inc.Executive Vice President and Treasurer2020–2021 (signatory dates) Signatory for capital markets instruments and corporate filings (e.g., credit agreements, preferred stock certificates, redemption-related filings)

External Roles

  • No external public-company board roles disclosed for Oliver in available MetLife investor materials .

Fixed Compensation

  • Not disclosed: Oliver is not listed among the Named Executive Officers (NEOs) with individual compensation reported in the proxy’s Summary Compensation Table .

Performance Compensation

MetLife’s executive LTI structure and annual incentive framework (applies enterprise-wide to executive officers; Oliver participates as a senior executive):

ComponentMetricWeightingTargetActual/PayoutVesting
Performance Shares (PSUs)Adjusted ROE vs Business Plan50% of PSU factor Three-year Business Plan goal; for 2024–2026 set within 15–17% range PSU performance factor determined after three years; overall PSU cap at 100% if absolute TSR ≤ 0% 3-year performance period; shares delivered based on factor
Performance Shares (PSUs)Relative TSR vs insurance TSR peer group50% of PSU factor Peer percentile targets: 25th=threshold, 50th=target, 87.5th=max 0–175% factor scale; overall PSU cap at 100% if absolute TSR ≤ 0% 3-year performance period; shares delivered based on factor
Restricted Stock Units (RSUs)Time-based30% of total LTI as of 2025 (options sunset) N/AN/AVests in thirds over 3 years (some grants cliff-vest at 3 years)
Annual Variable Incentive Plan (AVIP)Adjusted Earnings (with VII collar)Company-wide funding driver Funding calibrated to Business Plan; VII collar excludes >±10% VII swing 2024 AVIP funded at 101.4% of target company-wide Annual cash; individual payouts reflect role/performance

Notes:

  • LTI grant mix shifted to 70% PSUs / 30% RSUs in 2025; stock options ceased for new grants to align with investor feedback and market practice (no change to previously granted options) .
  • PSU factor scale: threshold 25%, target 100%, max 175% for each metric; combined with safeguards (negative absolute TSR cap) .

Equity Ownership & Alignment

  • Executive share ownership guidelines apply to SVP+ and executive officers, with required multiples of base salary and a 100% net-share retention rule until guidelines are met; NEOs disclosed as compliant (Oliver’s specific holdings/guideline status not disclosed) .
  • Hedging and pledging of MetLife securities are prohibited for directors and employees, including executive officers .
  • Stock-based award timing practices avoid MNPI timing; grants occur around regular February meetings .

Employment Terms

TopicTerms
Severance (no CIC)Officer-level severance generally equals 28 weeks of base salary plus 1 week per year of service, capped at 52 weeks; outplacement provided; pro-rata cash for certain forfeited awards depending on eligibility and separation agreement .
Change-in-Control (CIC) structureDouble-trigger; LTI may be substituted with equivalent awards; absent substitution, unvested PSUs/RSUs delivered at target on CIC; options may be accelerated/cashed for intrinsic value .
CIC Severance2x (base + average bonus of prior 3 years) and benefits continuation up to 3 years; modified cap to avoid excise tax; no gross-ups .
Restrictive covenantsPost-employment competitive service or violation of property/non-solicit/non-disparagement agreements can lead to forfeiture of awards; Rule of 65 preserves vesting in many cases for age+service ≥ 65 .

Vesting Schedules and Potential Insider Selling Pressure

  • RSUs generally vest in thirds over 3 years; certain retention/sign-on RSUs cliff-vest after 3 years .
  • PSUs vest after 3-year performance periods; payouts depend on Adjusted ROE and relative TSR factors .
  • Options (legacy grants) vest one-third annually over 3 years and have 10-year terms; no new options granted starting 2025 .
  • Insider transactions for Oliver not available in the proxy or filings reviewed; Form 4 data was not accessible via the insider trades tool within this session (no Oliver-specific selling data disclosed in these documents) .

Compensation Governance, Peer Group, and Say-on-Pay

  • Key program safeguards: clawbacks (performance-based and Dodd-Frank erroneous compensation), hedging/pledging prohibitions, CRO risk review of plans annually, negative TSR cap on PSU outcomes .
  • Comparator group (for pay benchmarking) spans global insurers and diversified financials; TSR peer group focuses on insurance competitors for PSU relative TSR .
  • Strong say-on-pay support: 95% in 2024; average ~96% since 2011, with shareholder engagement informing program design and option sunset decision .

Performance & Track Record (Asia Insights)

  • FX-rate dynamics in Japan and U.S. rates have supported foreign currency annuity product demand; however, currency fluctuations can temper uptake .
  • Q2 2025 Asia commentary: lower year-over-year earnings driven by weaker VII; strengthening yen reduced surrender income (near-term headwind) but improved persistency and supported AUM and future earnings outlook; underlying earnings expected to remain strong and in line with guidance .

Investment Implications

  • Alignment: Oliver’s pay is governed by MetLife’s performance-heavy design (70% PSUs in LTI, AVIP driven by Adjusted Earnings with a VII collar, hedging/pledging bans, clawbacks), which ties realized compensation strongly to ROE/TSR outcomes and mitigates misalignment risk .
  • Retention risk: Multi-year vesting and Rule of 65 provisions, coupled with net-share retention until guideline compliance, support retention of senior leaders; absence of single-trigger CIC severance and lack of tax gross-ups further align with shareholder-friendly practices .
  • Trading signals: No Oliver-specific insider sales data were found in the reviewed documents; without Form 4 visibility here, selling pressure signals cannot be assessed; program-wide safeguards reduce incentives for opportunistic trading .
  • Execution risk: Asia segment exposure to VII variability, FX, and surrender behavior creates reported-earnings volatility, but management commentary points to supportive sales/AUM trends and product economics improving with higher yen rates—factors to monitor for forward earnings trajectory under Oliver’s remit .